Dermal protein expression: Reviews citing biopsy-based work report increased collagen markers after topical GHK-Cu versus comparator creams in small cohorts, though methodologies vary and more robust trials are warranted (PMC
With a benign safety profile through six-month rodent toxicology and toxicology already taken to Phase II clinical evaluation in inflammatory bowel disease (PL 14736), BPC-157 stands as one of the few research peptides with a genuinely deep, reproducible evidence base
Clinicians then look to the clinical studies for a protocol

This stack is designed to support fat loss in a way that feels more metabolic than stimulant-driven. 1) Supports Fat Metabolism (AOD 9604) AOD 9604 is often used to support the bodys ability to: break down stored fat more effectively support lean tissue while dieting improve stuck progress when lifestyle habits are already in place 2) Supports Cellular Energy + Metabolic Flexibility (MOTS-c) MOTS-c is often chosen to support: mitochondrial energy production better fuel utilization (carbs/fats) improved metabolic efficiency and resilience 3) Supports Visceral Fat + Midsection Goals (Tesamorelin) Tesamorelin is often used to support: visceral fat reduction in certain individuals improved body composition over time metabolic support when stress, sleep, and hormones contribute to abdominal fat storage In simpler terms: AOD 9604 helps target fat metabolism, MOTS-c supports energy/efficiency, and Tesamorelin supports deeper midsection/visceral fat goals

Methods Samples In this study, 3D InSight TM Human Cardiac Microtissues (InSphero, for beta-testers) were used, containing a co-culture of approximately 4000 iPSC-derived human cardiomyocytes from a female Caucasian donor with no known disease phenotype and 1000 cardiac fibroblasts from an 18 year old Caucasian male